Drug Type Small molecule drug |
Synonyms dh404 |
Target |
Mechanism Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Preclinical | US | 01 Jul 2019 | |
Chronic Kidney Diseases | Preclinical | JP | 01 Jul 2019 | |
Diabetic Nephropathies | Preclinical | US | 01 Jul 2019 | |
Diabetic Nephropathies | Preclinical | JP | 01 Jul 2019 | |
Heart Diseases | Preclinical | US | 21 Dec 2009 |